Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2025-12-25 @ 1:05 AM
NCT ID:
NCT02599493
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (over 18 years old) who gave their signed inform consent,
* Who present an osteo-articular infection with susceptible Staphylococcus spp.,
* To whom a rifampicin based regimen is prescribed, in association with another antibiotic, for at least 14 days,
* Patients covered by Health Insurance.
Exclusion Criteria:
* Patients weighing less than 45 kg or more than 150 kg,
* Patients with active TB (whatever its localization),
* Patients needing the imperative use of a treatment presenting a contraindication for concomitant use in the SPC of Rimactan®
* Patients with a known and documented rifampicin allergy or severe rifampicin intolerance,
* Patients with galactose intolerance, total lactase deficiency or glucose or galactose malabsorption syndrome, or any other contraindication to the administration of Rimactan® listed in the SPC for Rimactan®
* Pregnant or breastfeeding woman,
* Adults legally protected (under judicial protection, guardianship or supervision), persons deprived of their liberty,
* Patients participating in another interventional clinical trial (biomedical trial or standard care clinical trial).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02599493
Study Brief:
Protocol Section:
NCT02599493